BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10556216)

  • 61. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
    Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
    Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
    [No Abstract]   [Full Text] [Related]  

  • 62. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.
    Kohlhammer H; Schwaenen C; Wessendorf S; Holzmann K; Kestler HA; Kienle D; Barth TF; Möller P; Ott G; Kalla J; Radlwimmer B; Pscherer A; Stilgenbauer S; Döhner H; Lichter P; Bentz M
    Blood; 2004 Aug; 104(3):795-801. PubMed ID: 15090459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma.
    Lossos IS; Thorstenson YR; Wayne TL; Oefner PJ; Levy R; Chu G
    Leuk Lymphoma; 2002 May; 43(5):1079-85. PubMed ID: 12148890
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization.
    Allen JE; Hough RE; Goepel JR; Bottomley S; Wilson GA; Alcock HE; Baird M; Lorigan PC; Vandenberghe EA; Hancock BW; Hammond DW
    Br J Haematol; 2002 Feb; 116(2):291-8. PubMed ID: 11841429
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
    Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
    Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.
    Bevan S; Catovsky D; Marossy A; Matutes E; Popat S; Antonovic P; Bell A; Berrebi A; Gaminara E; Quabeck K; Ribeiro I; Mauro FR; Stark P; Sykes H; van Dongen J; Wimperis J; Wright S; Yuille MR; Houlston RS
    Leukemia; 1999 Oct; 13(10):1497-500. PubMed ID: 10516748
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883del5.
    Ejima Y; Sasaki MS
    Hum Genet; 1998 Apr; 102(4):403-8. PubMed ID: 9600235
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
    Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
    Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The structure and organization of the human NPAT gene.
    Imai T; Sugawara T; Nishiyama A; Shimada R; Ohki R; Seki N; Sagara M; Ito H; Yamauchi M; Hori T
    Genomics; 1997 Jun; 42(3):388-92. PubMed ID: 9205109
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NS22: a highly polymorphic complex microsatellite marker within the ATM gene.
    Udar N; Farzad S; Tai LQ; Bay JO; Gatti RA
    Am J Med Genet; 1999 Feb; 82(4):287-9. PubMed ID: 10051159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.
    Menezes DL; Holt J; Tang Y; Feng J; Barsanti P; Pan Y; Ghoddusi M; Zhang W; Thomas G; Holash J; Lees E; Taricani L
    Mol Cancer Res; 2015 Jan; 13(1):120-9. PubMed ID: 25232030
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genomic organization of the ATM locus involved in ataxia-telangiectasia.
    Rasio D; Negrini M; Croce CM
    Cancer Res; 1995 Dec; 55(24):6053-7. PubMed ID: 8521392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of the ATM gene is significantly reduced in sporadic breast carcinomas.
    Waha A; Sturne C; Kessler A; Koch A; Kreyer E; Fimmers R; Wiestler OD; von Deimling A; Krebs D; Schmutzler RK
    Int J Cancer; 1998 Oct; 78(3):306-9. PubMed ID: 9766563
    [TBL] [Abstract][Full Text] [Related]  

  • 74. BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.
    Mertens D; Wolf S; Bullinger L; Ohl S; Schaffner C; Döhner H; Stilgenbauer S; Lichter P
    Int J Cancer; 2000 Dec; 88(5):692-7. PubMed ID: 11072235
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.
    Zhang P; Bhakta KS; Puri PL; Newbury RO; Feramisco JR; Wang JY
    Cancer Biol Ther; 2003; 2(1):87-91. PubMed ID: 12673126
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Harder S; Siebert R; Castoldi G; Calasanz MJ; Wong KF; Rosenwald A; Ott G; Atkin NB; Schlegelberger B
    Genes Chromosomes Cancer; 2000 Jan; 27(1):52-8. PubMed ID: 10564586
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Description of a 700-kb yeast artificial chromosome contig containing the BCL1 translocation breakpoint region at 11q13.
    Szepetowski P; Perucca-Lostanlen D; Grosgeorge J; LePaslier D; Brownstein BH; Carle GF; Gaudray P
    Cytogenet Cell Genet; 1995; 69(1-2):101-7. PubMed ID: 7835075
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.
    M'kacher R; Farace F; Bennaceur-Griscelli A; Violot D; Clausse B; Dossou J; Valent A; Parmentier C; Ribrag V; Bosq J; Carde P; Turhan AG; Bernheim A
    Cancer Genet Cytogenet; 2003 May; 143(1):32-8. PubMed ID: 12742154
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL).
    Lens D; Matutes E; Catovsky D; Coignet LJ
    Leukemia; 2000 Mar; 14(3):427-30. PubMed ID: 10720137
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ATM mutations in cancer families.
    Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
    Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.